Editas Medicine, Inc., Announces Offering of Common Stock
Dec 05, 2017 21:17 pm UTC| Business
CAMBRIDGE, Mass., Dec. 05, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it intends to offer and sell $50,000,000 of shares of its common stock in an underwritten...
Ramco-Gershenson Properties Trust Announces CEO Transition
Dec 05, 2017 21:15 pm UTC| Business
FARMINGTON HILLS, Mich., Dec. 05, 2017 -- Ramco-Gershenson Properties Trust (NYSE:RPT) (the “Company”) today announced that its Board of Directors and its President and Chief Executive Officer, Dennis Gershenson, have...
Gibson Energy Announces 2018 Capital Budget
Dec 05, 2017 21:15 pm UTC| Business
All financial figures are in Canadian dollars CALGARY, Alberta, Dec. 05, 2017 -- Gibson Energy Inc. (“Gibson” or the “Company”), (TSX:GEI), announced today that its Board of Directors has approved a 2018 growth...
PICO Holdings, Inc. Announces Agreement to Sell Up to 15,000 Long Term Storage Credits in Arizona
Dec 05, 2017 21:15 pm UTC| Business
LA JOLLA, Calif., Dec. 05, 2017 -- PICO Holdings, Inc. (NASDAQ:PICO) announced today that its wholly-owned subsidiary, Vidler Water Company, Inc., has entered in to an agreement to sell up to 15,000 Long Term Storage...
Dec 05, 2017 21:15 pm UTC| Business
NEW YORK, Dec. 05, 2017 -- Nasdaq (Nasdaq:NDAQ) today reported monthly volumes for November 2017 on its investor relations website. A data sheet showing the monthly volumes and quarterly capture rates can be found...
America First Multifamily Investors, L.P. Announces the Sale of Eagle Village MF Property
Dec 05, 2017 21:15 pm UTC| Business
OMAHA, Neb., Dec. 05, 2017 -- America First Multifamily Investors, L.P. (NASDAQ:ATAX) (the “Partnership”) announced today that on November 30, 2017, it sold Eagle Village, a 511 bed student housing property, held in its...
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dec 05, 2017 21:14 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 05, 2017 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on November 27, 2017, the Compensation Committee of the Board of Directors approved, effective as of...
FxWirePro- Major Economic events for the day